Jump to Navigation
Home

Main menu

  • Home
  • Latest Stories
  • Markets Map
  • Trends and Sentiments
  • Leading Topics
  • News Search
  • Comments and Analysis

Secondary menu

  • Latest News
  • Top Rated
  • Most Popular
  • Archive
  • About Us
  • 8 common words you probably didn't know came from TV...
  • Boeing Commercial Aircraft Deliveries Valued $13B
  • 1 In 4 Millennials Rely On Their Parents To Pay Some...
  • University expels frat over racist video
  • How a day in a UPS big rig opened my mind to trucking
  • A prescription for poverty? A career in nursing
  • Amid controversy, Martin Sorrell, head of the world'...
  • Be supportive: Women helping women in business
  • Paying billions more online: Supreme Court takes up...
  • Is it ever okay to cry at work?

    Merck to pay $950 million to settle U.S. Vioxx charge

    Wed, 11/23/2011 - 03:21 EDT - Reuters - Business News
    • businessNews

    (Reuters) - Merck & Co will pay roughly $950 million to settle criminal and civil charges that it promoted the painkiller Vioxx for an unapproved use, the U.S. Justice Department said on Tuesday.




    • Original article
    • Login to post comments
     

    Related

    • Merck to pay $950 million to settle U.S. Vioxx charge (Reuters)

      Reuters - Merck & Co will pay roughly $950 million to settle criminal and civil charges that it promoted the painkiller Vioxx for an unapproved use, the U.S. Justice Department said on Tuesday.

    • Merck to pay $950 million to settle U.S. Vioxx charge

      Merck & Co will pay roughly $950 million to settle criminal and civil charges that it promoted the painkiller Vioxx for an unapproved use, the U.S. Justice Department said on Tuesday. The fine will conclude ...

    • Merck to pay nearly $1 billion to settle U.S. charges (Reuters)

      Reuters - Merck & Co will pay roughly $950 million to settle criminal and civil charges that it promoted the painkiller drug Vioxx for an unapproved use, the U.S. Justice Department said on Tuesday.

    • Merck to pay nearly $1 billion to settle U.S. charges

      (Reuters) - Merck & Co will pay roughly $950 million to settle criminal and civil charges that it promoted the painkiller drug Vioxx for an unapproved use, the U.S.

    • Merck to pay nearly $1 billion over Vioxx

      Merck & Co will pay roughly $950 million to settle criminal and civil charges that it promoted the painkiller drug Vioxx for an unapproved use, the DOJ said on Tuesday.

    • Merck Pays $950M To Settle Vioxx Criminal And Civil Settlement

      By The Burrill Report: Merck (MRK) will pay $950 million to settle criminal and civil charges related to the improper promotion and marketing of the painkiller Vioxx. The U.S. Department of Justice say Merck will pay $321.6 million in criminal fines and $628.4 as part of a civil settlement. The company also pleaded guilty to a misdemeanor charge that it marketed Vioxx for off-label use.

    • Merck to Pay $950 Million in Vioxx Settlement

      Merck will pay $950 million to settle criminal and civil charges that it illegally promoted the painkiller Vioxx, the Justice Department announced.

    • Merck to Settle Charges Over Vioxx

      Merck will pay $950 million to settle criminal and civil charges that it illegally promoted the painkiller Vioxx, the Justice Department announced.

    • US says Merck to pay $950 mn for Vioxx marketing

      Pharmaceutical giant Merck will pay nearly $1 billion to resolve criminal and civil charges for mismarketing the painkiller Vioxx, the US Department of Justice said Tuesday.Merck agreed to plead guilty to one count of breaking the Food Drug and Cosmetic Act and to one criminal misdemeanor, after it promoted Vioxx for rheumatoid arthritis when the drug had not been approved for that disease, a government statement said.

    • Merck fined $950 mn over painkiller marketing

      Pharmaceutical giant Merck will pay nearly $1 billion to resolve criminal and civil charges for wrongfully marketing its former hit painkiller Vioxx, the US Department of Justice said.Merck agreed to plead guilty to breaking the Food Drug and Cosmetic Act after it promoted Vioxx for rheumatoid arthritis when the drug had not been approved for that disease, the department statement said in a statement.The criminal fine amounts to $321.6 million.

    Latest

    8 common words you probably didn't know came from TV shows
    8 common words you probably didn't know came...
    "The House Always Wins": These Funds Made A Killing As Bitcoin Plunged
    "The House Always Wins": These Funds...

    Markets Map

    Markets Map

    Follow Us

    Follow Us on Facebook, Twitter, Google Plus and RSS LinkedIn Facebook Twitter Google Plus RSS
    S&P 500: 2579.37 0.16% FTSE: 7487.96 -0.07% Nikk.: 22420.08 1.82% DAX: 13465.51 1.75% HSI: 28594.06 1.22% FX: EUR/GBP: 1.1401 USD/EUR: 1.1618 JPY/USD: 114.1510 Commodities: Gold: 1276.1000

    Bullfax.com - Market News & Analysis 2008-2011
    Contact Us | About Us | Terms & Conditions

    Follow Us on Facebook, Twitter, Google Plus and RSS LinkedIn Facebook Twitter Google Plus RSS .

    Secondary menu

    • Latest News
    • Top Rated
    • Most Popular
    • Archive
    • About Us